Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab (Q41482012)

1 October 2017

Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab (English)

1 reference

1 October 2017

Michael S Ominsky

1

1 reference

1 October 2017

Cesar Libanati

2

1 reference

1 October 2017

Qing-Tian Niu

3

1 reference

1 October 2017

Rogely W Boyce

4

1 reference

1 October 2017

Paul J Kostenuik

5

1 reference

1 October 2017

Rachel B Wagman

6

1 reference

1 October 2017

Roland Baron

7

1 reference

1 October 2017

David W Dempster

8

1 reference

1 October 2017

1 July 2015

1 reference

Journal of Bone and Mineral Research

1 October 2017

1 reference

1 October 2017

30

1 reference

1 October 2017

7

1 reference

1 October 2017

1280-1289

1 reference

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 October 2017

1 reference

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

21 January 2018

1 reference

Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody

21 January 2018

1 reference

Structural adaptations to bone loss in aging men and women

21 January 2018

1 reference

Subperiosteal expansion and cortical remodeling of the human femur and tibia with aging

21 January 2018

1 reference

Effect of long-term impact-loading on mass, size, and estimated strength of humerus and radius of female racquet-sports players: a peripheral quantitative computed tomography study between young and old starters and controls

21 January 2018

1 reference

Bone loss and bone size after menopause

21 January 2018

1 reference

Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.

21 January 2018

1 reference

Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys

21 January 2018

1 reference

Nonhuman primate models in skeletal research

21 January 2018

1 reference

Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites

21 January 2018

1 reference

Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice.

21 January 2018

1 reference

Bone structure and metabolism in a rodent model of male senile osteoporosis.

21 January 2018

1 reference

Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys

21 January 2018

1 reference

A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide

21 January 2018

1 reference

Periosteal remodeling at the femoral neck in nonhuman primates

21 January 2018

1 reference

Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography

21 January 2018

1 reference

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

21 January 2018

1 reference

Annual intravenous zoledronic acid for three years increased cancellous bone matrix mineralization beyond normal values in the HORIZON biopsy cohort.

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.2480

1 reference

1 October 2017

1 reference